Quay lại
Giá Healios K.K. (HLOSF)
Biểu đồ giá cổ phiếu HLOSF
HLOSF Thu nhập
Healios K.K.
$2.1
8.8%
$0.17
Khi đóng cửa: Jan 16, 16:00:00 GMT-5
$2.1
0%
$0
Phiên sau giờ: Jan 16, 20:00:00 GMT-5
Thống kê chính
Giá đóng cửa trước
$1.93
Giá mở cửa
$2.1
Phạm vi ngày
$2.1 - $2.1
Phạm vi 52 tuần
$0.96 - $4.45
Khối lượng
200
Khối lượng trung bình
150
EPS (TTM)
-0.39
Tỷ suất cổ tức
--
Vốn hóa thị trường
$242.3M
HEALIOS K K là gì?
Healios KK engages in the research, development, and sale of cellular and regenerative medicine. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 65 full-time employees. The company went IPO on 2015-06-16. The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.
Đặc điểm
Chiến lược giao dịch
Tài nguyên
© 2025 Finture Development Limited. All rights reserved